Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course glucocorticoid strategies in chronic rhinosinusitis with nasal polyps
ChiCTR1900023434Phase 4Recruiting
- Sponsor
- Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide and methylprednisolone in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms), sponsored by Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University. Primary endpoint: Total nasal symptom score. Started Jan 2018; status: recruiting.
02
Drugs
budesonidemethylprednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on ChiCTR1900023434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023434.